| Successor | Predecessor | |||||||
| December 31, 2023 | December 31, 2022 | |||||||
| Deferred tax assets: | ||||||||
| Net operating loss carryforward | $ | 3,580 | $ | 3,315 | ||||
| Property and equipment and intangible assets | 155 | 44 | ||||||
| Other tax carry-overs | 613 | — | ||||||
| Stock-based compensation | 893 | 569 | ||||||
| Reserves and allowances | 85 | 38 | ||||||
| Total deferred tax assets | 5,326 | 3,966 | ||||||
| Deferred tax liabilities: | ||||||||
| Book basis of intangible assets in excess of tax basis | 3,650 | 54 | ||||||
| Total deferred tax liabilities | 3,650 | 54 | ||||||
| Net deferred tax asset before valuation allowance | 1,676 | 3,912 | ||||||
| Less: valuation allowance | (1,676) | (3,912) | ||||||
| Net deferred tax asset | $ | — | $ | — | ||||
| For the Years Ended | ||||||||
| December 31, | ||||||||
| 2023 | 2022 | |||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
| Net loss | $ | (12,407) | $ | (9,161) | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation expense | 758 | 465 | ||||||
| Change in provision for doubtful accounts | 47 | — | ||||||
| Amortization of intangible assets | 1,337 | 25 | ||||||
| Amortization of right-of-use assets - operating leases | 417 | 106 | ||||||
| Amortization of right-of-use assets - finance leases | 15 | — | ||||||
| Write-off of digital assets | 28 | 43 | ||||||
| Goodwill impairment | 13,895 | — | ||||||
| Gain on remeasurement of fair value of equity interest in affiliate prior to acquisition | (11,352) | — | ||||||
| Equity in net loss of affiliate | 1,440 | 1,739 | ||||||
| Stock-based compensation | 5,376 | 2,974 | ||||||
| Change in operating assets and liabilities: | ||||||||
| Accounts receivable | (3,449) | (34) | ||||||
| Inventory | (2,217) | (267) | ||||||
| Unbilled revenue | (47) | (41) | ||||||
| Prepaid expense | 22 | 52 | ||||||
| Notes receivable | (256) | — | ||||||
| Other assets | — | 49 | ||||||
| VAT receivable | 91 | 59 | ||||||
| Accounts payable and accrued expenses | 3,231 | 453 | ||||||
| Operating lease liabilities | (464) | (101) | ||||||
| Income taxes payable | 45 | 37 | ||||||
| Contract liabilities | 6 | — | ||||||
| Liabilities from discontinued operations | (112) | — | ||||||
| Net cash used in operating activities | (3,596) | (3,602) | ||||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
| Purchase of property and equipment | (647) | (716) | ||||||
| Cash acquired in acquisition of subsidiary | 7,352 | — | ||||||
| Capital contributions to equity method investee | (1,506) | (7,000) | ||||||
| Net cash provided by (used in) investing activities | 5,199 | (7,716) | ||||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
| Repayments of note payable, related party, net | (10) | (7) | ||||||
| Issuance of common stock for PIPE transaction | 6,000 | 13,832 | ||||||
| Payment of stock issuance costs | — | (754) | ||||||
| Proceeds from exercise of warrants | 184 | — | ||||||
| Payments on finance lease liabilities | (15) | — | ||||||
| Repayments of notes payable | (299) | (60) | ||||||
| Net cash provided by financing activities | 5,860 | 13,011 | ||||||
| Effect of exchange rate on cash | (47) | (70) | ||||||
| Net increase in cash | 7,416 | 1,623 | ||||||
| Cash beginning of year | 18,891 | 17,268 | ||||||
| Cash end of year | $ | 26,307 | $ | 18,891 | ||||
| SUPPLEMENTAL CASH FLOW INFORMATION | ||||||||
| Cash paid during the period for: | ||||||||
| Interest | $ | 531 | $ | 11 | ||||
| Income tax | $ | — | $ | 10 | ||||
| Supplemental schedule of non-cash investing and financing activities: | ||||||||
| Business combination without transfer of consideration | $ | 39,859 | $ | — | ||||
| Successor | Predecessor | |||||||||||
| Six Months Ended December 31, 2023 | Six Months Ended June 30, 2023 | Year Ended December 31, 2022 | ||||||||||
| Current: | ||||||||||||
| Federal | $ | — | $ | — | $ | — | ||||||
| State | — | — | — | |||||||||
| Total current | — | — | — | |||||||||
| Deferred: | ||||||||||||
| Federal | — | — | — | |||||||||
| State | — | — | 1 | |||||||||
| Total deferred | — | — | 1 | |||||||||
| Total income tax provision | $ | — | $ | — | $ | 1 | ||||||
| Year Ended | ||||||||
| December 31, | ||||||||
| 2023 | 2022 | |||||||
| Income tax (benefit) provision: | ||||||||
| Current | ||||||||
| Federal | $ | (11) | $ | — | ||||
| State | — | — | ||||||
| Foreign | 39 | 87 | ||||||
| Total current | 28 | 87 | ||||||
| Deferred: | ||||||||
| Federal | — | — | ||||||
| State | — | — | ||||||
| Foreign | — | — | ||||||
| Total deferred | — | — | ||||||
| Total income tax (benefit) provision | $ | 28 | $ | 87 | ||||
| Purchase Price Allocation | ||||
| Total purchase consideration | $ | 16,679 | ||
| Fair value of non-controlling interest | 23,180 | |||
| Total consideration | $ | 39,859 | ||
| Identifiable net assets acquired: | ||||
| Cash | $ | 7,352 | ||
| Accounts receivable, net | 6,478 | |||
| Accounts receivable, other | 506 | |||
| Inventory | 1,631 | |||
| Prepaid expenses | 220 | |||
| Property and equipment, net | 2,883 | |||
| Right of use assets, net | 405 | |||
| Intangible assets, net: | ||||
| Trade name | 4,700 | |||
| Development technology | 2,880 | |||
| Pharmacy records | 8,130 | |||
| Deposits | 39 | |||
| Accounts payable and accrued expenses | (8,231) | |||
| Notes payable and accrued interest - current portion | (149) | |||
| Lease liabilities - current portion | (208) | |||
| Notes payable - long term | (1,173) | |||
| Lease liabilities - long term | (230) | |||
| Deferred tax liability (1) | — | |||
| Net assets acquired | $ | 25,233 | ||
| Goodwill | $ | 14,626 | ||
